Synopsys INC Form 4 insider transactions

Sassine Ghazi, PRESIDENT AND CEO and a Director of Synopsys Inc, sold 14,604 shares of common stock on October 15, 2026 for $462.84 per share.

Janet Lee, GC & Corporate Secretary of Synopsys Inc, sold 1,144 shares of common stock on October 6, 2026.

Sudhindra Kankanwadi, Deputy CFO & CAO of Synopsys Inc, sold 12,170 shares of common stock on October 5, 2026.

Sassine Ghazi, PRESIDENT AND CEO and a Director of Synopsys Inc, sold 14,604 shares of common stock on September 15, 2026 for $374.88 per share.

Janet Lee, GC & Corporate Secretary of Synopsys Inc, reported multiple transactions in common stock on September 1, 2026.

Sassine Ghazi, PRESIDENT AND CEO and a Director of Synopsys Inc, reported a transaction in 27 shares of common stock on August 31, 2026.

Sudhindra Kankanwadi, Deputy CFO & CAO of Synopsys Inc, reported a transaction in 27 shares of common stock on August 31, 2026.

Michael Ellow, Chief Revenue Officer of Synopsys Inc, reported a transaction in 27 shares of common stock on August 31, 2026.

Geus Aart De, EXECUTIVE CHAIR and a Director of Synopsys Inc, sold 49,641 shares of common stock on August 31, 2026.

Geus Aart De, EXECUTIVE CHAIR and a Director of Synopsys Inc, sold 25,000 shares of common stock on August 28, 2026 for $445.55 per share.

Janet Lee, GC & Corporate Secretary of Synopsys Inc, reported multiple transactions in common stock on August 16, 2026.

Synopsys Chief Revenue Officer Michael Ellow acquired 5,128 shares through RSU vesting and disposed of 2,543 shares for tax obligations.

Synopsys General Counsel Janet Lee acquired 540 shares via RSU vesting and withheld 235 shares for tax obligations.

Deputy CFO and CAO Sudhindra Kankanwadi acquired 720 shares of Synopsys common stock via RSU vesting and disposed of 249 shares for tax obligations.

Synopsys CFO Shelagh Glaser acquired 1,259 shares via restricted stock unit vesting and withheld 436 shares for tax obligations.

Synopsys CEO Sassine Ghazi exercised stock options and sold shares as part of a pre-arranged Rule 10b5-1 trading plan.

Executive Chair Aart de Geus acquired 449 shares of Synopsys common stock through the vesting of restricted stock units.

Synopsys Inc. CFO Shelagh Glaser executed a Rule 10b5-1 trading plan, resulting in the sale of 3,394 shares of common stock.

Synopsys GC & Corporate Secretary Janet Lee reported transactions involving Synopsys Inc. common stock, including the acquisition of shares related to restricted stock units and tax withholding.

Director Jesse Cohn of Synopsys Inc. has reported the acquisition of common stock through an automatic award under the company's equity incentive plan.

Synopsys General Counsel Janet Lee reported the vesting of restricted stock units and a subsequent tax-related share disposition.

Synopsys Director Ravi K. Vijayaraghavan was granted 453 shares of common stock as an automatic equity incentive award.

Director Peter A. Shimer acquired 453 shares of Synopsys common stock via an automatic equity incentive plan award.

Director John Schwarz acquired 453 shares of Synopsys common stock via an automatic equity incentive plan award.

Director Jeannine Sargent was granted 453 shares of Synopsys common stock as part of an automatic equity incentive plan.

Director Robert G. Painter was granted 453 shares of Synopsys common stock as part of an automatic equity incentive plan.

Director Mercedes Johnson received an automatic equity grant of 453 shares of Synopsys common stock.

Director Bruce Chizen was granted 453 shares of Synopsys common stock as part of an automatic equity incentive plan.

Director Janice Chaffin acquired 453 shares of Synopsys common stock as part of an automatic equity incentive plan award.

Synopsys' Chief Accounting Officer, Sudhindra Kankanwadi, exercised restricted stock units and sold a portion of the resulting common stock to cover tax obligations.